Suppr超能文献

纤溶酶原激活物抑制剂1。天然丝氨酸蛋白酶抑制剂的结构,与其他构象的比较及其对丝氨酸蛋白酶抑制剂失活的影响。

Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.

作者信息

Nar H, Bauer M, Stassen J M, Lang D, Gils A, Declerck P J

机构信息

Department of Chemistry, Boehringer Ingelheim Pharma KG, Biberach, Germany.

出版信息

J Mol Biol. 2000 Mar 31;297(3):683-95. doi: 10.1006/jmbi.2000.3604.

Abstract

The crystal structure of a constitutively active multiple site mutant of plasminogen activator inhibitor 1 (PAI-1) was determined and refined at a resolution of 2.7 A. The present structure comprises a dimer of two crystallographically independent PAI-1 molecules that pack by association of the residues P6 to P3 of the reactive centre loop of one molecule (A) with the edge of the main beta-sheet A of the other molecule (B).Thus, the reactive centre loop is ordered for molecule A by crystal packing forces, while for molecule B it is unconstrained by crystal packing contacts and is disordered. The overall structure of active PAI-1 is similar to the structures of other active inhibitory serpins exhibiting as the major secondary structural feature a five-stranded beta-sheet A and an intact proteinase-binding loop protruding from the one end of the elongated molecule. No preinsertion of the reactive centre loop is observed in this structure.A comparison of the present structure with the previously determined crystal structures of PAI-1 in its alternative conformations reveals that, upon cleavage of an intact form of PAI-1 or formation of latent PAI-1, the well-characterised rearrangements of the serpin secondary structural elements are accompanied by dramatic and partly unexpected conformational changes of helical and loop structures proximal to beta-sheet A. The present structure explains the stabilising effects of the mutated residues, reveals the structural cause for the observed spectroscopic differences between active and latent PAI-1, and provides new insights into possible mechanisms of stabilisation by its natural binding partner, vitronectin.

摘要

纤溶酶原激活物抑制剂1(PAI-1)组成型活性多位点突变体的晶体结构已被确定,并以2.7埃的分辨率进行了优化。目前的结构由两个晶体学独立的PAI-1分子组成二聚体,一个分子(A)反应中心环的P6至P3残基与另一个分子(B)主β-折叠A的边缘通过缔合堆积在一起。因此,反应中心环通过晶体堆积力对分子A有序排列,而对于分子B,它不受晶体堆积接触的限制且无序。活性PAI-1的整体结构与其他活性抑制性丝氨酸蛋白酶抑制剂的结构相似,主要二级结构特征为五链β-折叠A和从细长分子一端突出的完整蛋白酶结合环。在该结构中未观察到反应中心环的预插入。将目前的结构与先前确定的PAI-1其他构象的晶体结构进行比较,结果表明,在完整形式的PAI-1被切割或潜伏性PAI-1形成时,丝氨酸蛋白酶抑制剂二级结构元件的特征性重排伴随着β-折叠A附近螺旋和环结构的显著且部分出乎意料的构象变化。目前的结构解释了突变残基的稳定作用,揭示了活性和潜伏性PAI-1之间观察到的光谱差异的结构原因,并为其天然结合伴侣玻连蛋白可能的稳定机制提供了新见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验